Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Xpress Analyse ApS
APS
Active
Advertising protection
CVR 44308908
Østeralle 23, 8400
Ebeltoft
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2023 · 2 years old
1 employees
www.coronalifecare.dk
Monitor
Share
Denmark
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Xpress Analyse ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
0M
0M
-1M
-1M
0M
2024
0M
0%
2025
EBITDA
DKK millions
0M
0M
0M
-1M
-1M
0M
2024
0M
0%
2025
Income statement
DKK thousands
Item
2024
2025
Gross profit
186
8
Staff expenses
-123
-2
EBITDA
64
6
Depreciation & amort.
-0
-0
EBIT
64
6
Net financials
-0
0
Profit before tax
64
6
Tax
14
2
Net profit
50
5
Balance sheet
DKK thousands
Item
2024
2025
Total assets
140
111
Equity
90
94
Long-term debt
0
0
Short-term debt
51
16
Total debt
51
16
Financial ratios
5-year trend
EBITDA margin (of gross profit)
75.4%
This company
2024
2025
Equity ratio
85.3%
This company
38.2%
Market median
123% above market
2024
2025
Return on equity
4.9%
This company
18.4%
Market median
73% below market
2024
2025
Net profit margin (of gross profit)
58.7%
This company
2024
2025
Asset turnover (of gross profit)
0.07×
This company
2024
2025
Debt / equity
0.17×
This company
0.62×
Market median
73% below market
2024
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2024-07-01 – 2025-06-30
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2023-09-15 – 2024-06-30
View
PDF
More on Xpress Analyse ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
